Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9344511 | 0.84 | TSHR (0.42) | ESR1ESR2APPNR4A2RXRA | |
| SCHEMBL9343512 | 0.84 | TSHR (0.42) | ESR1ESR2APPNR4A2RXRA | |
| SCHEMBL10601214 | 0.82 | ESR1 (0.48) | ESR1ESR2APPNR4A2RXRA | |
| SCHEMBL780050 | 0.82 | APP (0.53) | APPNR4A2RXRARXRBMEN1 | |
| SCHEMBL9876082 | 0.81 | PTPN2 (0.50) | ESR1ESR2APPNR4A2RXRA | |
| SCHEMBL11308991 | 0.79 | APP (0.41) | ESR1ESR2APPNR4A2RXRA | |
| SCHEMBL24533723 | 0.79 | APP (0.61) | APPNR4A2RXRARXRBHRH3 | |
| SCHEMBL9347553 | 0.79 | PTPN2 (0.49) | ESR1ESR2APPNR4A2RXRA | |
| SCHEMBL9342878 | 0.79 | PTPN2 (0.49) | ESR1ESR2APPNR4A2RXRA | |
| SCHEMBL18911060 | 0.79 | ESR1 (0.39) | ESR1ESR2APPNR4A2RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2534281-B1 | METHOD FOR PRODUCING 4-ISOPROPYLCYCLOHEXYLMETHANOL | BASF SE (DE) | 2019-01-09 | — | — | EP | disclosed |
| US-20110207968-A1 | PROCESS FOR PREPARING 4-ISOPROPYLCYCLOHEXYLMETHANOL | BASF SE (DE) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207968-A1 | PROCESS FOR PREPARING 4-ISOPROPYLCYCLOHEXYLMETHANOL | CYP2E1, CYP3A4, DHPS | ESR1 2660/4885ESR2 3066/4885APP 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.